Houston Eye Associates Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00273455
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

The Eye Clinic of Texas, affiliate Houston Eye Associates

Active Ingredients

Drugs in Phase 4 Trials (3)

bimatoprost (lumigan) (1 trial)

dorzolamide (trusopt) (1 trial)

timolol (blocadren) (1 trial)

Drugs in Phase 3 Trials (1)

loteprednol (lotemax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eye Infections (Phase 3)

Glaucoma, Open-Angle (Phase 4)

Inflammation (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4